533265 Design of an Optimal Temporal Immunization Strategy for Evolving Broadly Neutralizing Antibodies Against HIV

Kayla Sprenger, Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, Joy Louveau, Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA and Arup Chakraborty, Ragon Institute of MGH, MIT and Harvard, Institute for Medical Engineering & Science, Departments of Chemical Engineering, Physics, Chemistry, & Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA
See more of this Session: Applications in Immunology and Immunotherapy
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division